TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Scandinavian Biopharma Distribution AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
103,694
|
81,384
|
68,570 |
Financial expenses |
266
|
335
|
140 |
Earnings before taxes |
20,650
|
21,232
|
15,578 |
EBITDA |
20,425
|
21,521
|
15,718 |
Total assets |
56,094
|
45,243
|
32,542 |
Current assets |
55,353
|
44,951
|
32,176 |
Current liabilities |
17,871
|
18,715
|
12,600 |
Equity capital |
648
|
634
|
678 |
- share capital |
34
|
33
|
36 |
Employees (average) |
4
|
3
![]() |
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
1.2%
|
1.4%
|
2.1% |
Turnover per employee |
25,924
|
27,128
|
22,857 |
Profit as a percentage of turnover |
19.9%
|
26.1%
|
22.7% |
Return on assets (ROA) |
37.3%
|
47.7%
|
48.3% |
Current ratio |
309.7%
|
240.2%
|
255.4% |
Return on equity (ROE) |
3186.7%
|
3348.9%
|
2297.6% |
Change turnover |
21,891
|
18,368
|
8,844 |
Change turnover % |
27%
|
29%
|
15% |
Chg. No. of employees |
1
|
0
|
1 |
Chg. No. of employees % |
33%
|
0%
|
50% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.